DHG Pharmaceutical JSCSTC:DHG 77 Operating Margin % is 27.48% as of Mar. 2026, which is 42% above its 10-year median of 19.31. GuruFocus rates STC:DHG with a GF Score™ of 77/100 and a GF Value™ of ₫113,344.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 955 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks better than 80.42% on this metric.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
DHG Pharmaceutical JSC Operating Margin % Related Terms
DHG Pharmaceutical JSC Operating Margin % Historical Data
* Premium members only.
The historical data trend for DHG Pharmaceutical JSC's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Operating Margin % distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
DHG Pharmaceutical JSC's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a Operating Margin % of 27.48% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on DHG Pharmaceutical JSC and its competitors. This is 42% above median its historical median of 19.31. Over the past decade, DHG Pharmaceutical JSC's Operating Margin % has ranged from 17.54 to 22.99. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #187 out of 955 companies in the Drug Manufacturers industry, placing it in the top 19.6%.
Is DHG Pharmaceutical JSC's Operating Margin % too high?
DHG Pharmaceutical JSC's current Operating Margin % of 27.48% is 42% above median its 10-year median of 19.31. Over the past 10 years, this metric has ranged from a low of 17.54 to a high of 22.99. The Drug Manufacturers industry median Operating Margin % is 7.45. DHG Pharmaceutical JSC's value of 27.48% is 268.9% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #187 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, DHG Pharmaceutical JSC has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #187 out of 955 companies for Operating Margin %. This places DHG Pharmaceutical JSC in the top 20% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.45. DHG Pharmaceutical JSC's value of 27.48% is 268.9% above this benchmark. Historically, DHG Pharmaceutical JSC's own Operating Margin % has ranged from 17.54 to 22.99 over the past decade. While the company's 10-year median is 19.31 vs. the industry median of 7.45, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.45, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current Operating Margin % of 27.48% is 268.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current Operating Margin % is 27.48%, which is 42% above median its own 10-year median of 19.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,344.20, compared to a current price of ₫94,700.00 — trading 16.4% below its estimated fair value. The current Operating Margin % is 27.48%, which is 42% above median its 10-year median of 19.31 and 268.9% above the Drug Manufacturers industry median of 7.45. DHG Pharmaceutical JSC's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Operating Margin % is 27.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫94,700.00 is trading 16.4% below its estimated GF Value™ of ₫113,344.20.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
Operating Margin %: 27.48% (42% above median its 10-year median of 19.31)
GF Value™: ₫113,344.20 vs. price of ₫94,700.00 (16.4% below fair value)
Industry Position: 268.9% above the Drug Manufacturers median (#187 of 955)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
77GF Score
Get the complete analysis for STC:DHG
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
